This TAOK inhibitor reduced aberrant tau phosphorylation in induced pluripotent stem cell‐derived neurons (iPSCs) from FTLD patients, as well as cortical neurons from a transgenic mouse model of tauopathy (Giacomini et al. 2018). The gene discussed is MAPT; the disease is tauopathy.